2025-523058-16-00
CTIS ↗
CLEER-001
Skin Toxicities Associated with Epidermal Growth Factor Receptor Inhibitors
pharma · Skin Toxicities Associated with Epidermal Growth Factor Receptor Inhibitors · Atopic Dermatitis · HOTH
Hoth Therapeutics
Hoth Therapeutics trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.
Norwich, GB HQ
12 Employees
Public company Type
HOTH · NYSE Ticker
Company details
- Status
- Public
- HQ
- Norwich, GB
- Employees
- 12
- Programs
- 3
- Drugs
- 4
- Patents
- 1
Hoth Therapeutics clinical trials
Registry index of 3 ClinicalTrials.gov studies linked to Hoth Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Hoth Therapeutics trial registry — 3 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Hoth Therapeutics.